Curis
CRIS • NASDAQ
Curis is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James E. Dentzer, with a market cap of $22.2M.
Market Cap$22.2M
Employees49.0
CEOJames E. Dentzer
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Curis FAQ
Common questions about Curis
Curis is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $2.3M.
Curis has approximately 49 employees.